1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Development Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Biostatistics
1.2.3 Data Management
1.2.4 Clinical Trial Monitoring
1.2.5 Clinical Trial Project Management (Phase I-Iv)
1.2.6 Regulatory Affairs
1.2.7 Pharmacovigilance
1.2.8 Other
1.3 Market by Application
1.3.1 Global Clinical Development Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clinical Development Services Market Perspective (2017-2028)
2.2 Clinical Development Services Growth Trends by Region
2.2.1 Clinical Development Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Clinical Development Services Historic Market Size by Region (2017-2022)
2.2.3 Clinical Development Services Forecasted Market Size by Region (2023-2028)
2.3 Clinical Development Services Market Dynamics
2.3.1 Clinical Development Services Industry Trends
2.3.2 Clinical Development Services Market Drivers
2.3.3 Clinical Development Services Market Challenges
2.3.4 Clinical Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Development Services Players by Revenue
3.1.1 Global Top Clinical Development Services Players by Revenue (2017-2022)
3.1.2 Global Clinical Development Services Revenue Market Share by Players (2017-2022)
3.2 Global Clinical Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Development Services Revenue
3.4 Global Clinical Development Services Market Concentration Ratio
3.4.1 Global Clinical Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Development Services Revenue in 2021
3.5 Clinical Development Services Key Players Head office and Area Served
3.6 Key Players Clinical Development Services Product Solution and Service
3.7 Date of Enter into Clinical Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Development Services Breakdown Data by Type
4.1 Global Clinical Development Services Historic Market Size by Type (2017-2022)
4.2 Global Clinical Development Services Forecasted Market Size by Type (2023-2028)
5 Clinical Development Services Breakdown Data by Application
5.1 Global Clinical Development Services Historic Market Size by Application (2017-2022)
5.2 Global Clinical Development Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Clinical Development Services Market Size (2017-2028)
6.2 North America Clinical Development Services Market Size by Country (2017-2022)
6.3 North America Clinical Development Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Clinical Development Services Market Size (2017-2028)
7.2 Europe Clinical Development Services Market Size by Country (2017-2022)
7.3 Europe Clinical Development Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Development Services Market Size (2017-2028)
8.2 Asia-Pacific Clinical Development Services Market Size by Country (2017-2022)
8.3 Asia-Pacific Clinical Development Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Clinical Development Services Market Size (2017-2028)
9.2 Latin America Clinical Development Services Market Size by Country (2017-2022)
9.3 Latin America Clinical Development Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Development Services Market Size (2017-2028)
10.2 Middle East & Africa Clinical Development Services Market Size by Country (2017-2022)
10.3 Middle East & Africa Clinical Development Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Syneos Health
11.1.1 Syneos Health Company Detail
11.1.2 Syneos Health Business Overview
11.1.3 Syneos Health Clinical Development Services Introduction
11.1.4 Syneos Health Revenue in Clinical Development Services Business (2017-2022)
11.1.5 Syneos Health Recent Development
11.2 PPD
11.2.1 PPD Company Detail
11.2.2 PPD Business Overview
11.2.3 PPD Clinical Development Services Introduction
11.2.4 PPD Revenue in Clinical Development Services Business (2017-2022)
11.2.5 PPD Recent Development
11.3 GVI CDS
11.3.1 GVI CDS Company Detail
11.3.2 GVI CDS Business Overview
11.3.3 GVI CDS Clinical Development Services Introduction
11.3.4 GVI CDS Revenue in Clinical Development Services Business (2017-2022)
11.3.5 GVI CDS Recent Development
11.4 Parexel
11.4.1 Parexel Company Detail
11.4.2 Parexel Business Overview
11.4.3 Parexel Clinical Development Services Introduction
11.4.4 Parexel Revenue in Clinical Development Services Business (2017-2022)
11.4.5 Parexel Recent Development
11.5 Clinical Leader
11.5.1 Clinical Leader Company Detail
11.5.2 Clinical Leader Business Overview
11.5.3 Clinical Leader Clinical Development Services Introduction
11.5.4 Clinical Leader Revenue in Clinical Development Services Business (2017-2022)
11.5.5 Clinical Leader Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Clinical Development Services Introduction
11.6.4 Thermo Fisher Scientific Revenue in Clinical Development Services Business (2017-2022)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 LabCorp
11.7.1 LabCorp Company Detail
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Clinical Development Services Introduction
11.7.4 LabCorp Revenue in Clinical Development Services Business (2017-2022)
11.7.5 LabCorp Recent Development
11.8 Worldwide Clinical Trial
11.8.1 Worldwide Clinical Trial Company Detail
11.8.2 Worldwide Clinical Trial Business Overview
11.8.3 Worldwide Clinical Trial Clinical Development Services Introduction
11.8.4 Worldwide Clinical Trial Revenue in Clinical Development Services Business (2017-2022)
11.8.5 Worldwide Clinical Trial Recent Development
11.9 CROS NT
11.9.1 CROS NT Company Detail
11.9.2 CROS NT Business Overview
11.9.3 CROS NT Clinical Development Services Introduction
11.9.4 CROS NT Revenue in Clinical Development Services Business (2017-2022)
11.9.5 CROS NT Recent Development
11.10 Dynakin
11.10.1 Dynakin Company Detail
11.10.2 Dynakin Business Overview
11.10.3 Dynakin Clinical Development Services Introduction
11.10.4 Dynakin Revenue in Clinical Development Services Business (2017-2022)
11.10.5 Dynakin Recent Development
11.11 Rho, Inc.
11.11.1 Rho, Inc. Company Detail
11.11.2 Rho, Inc. Business Overview
11.11.3 Rho, Inc. Clinical Development Services Introduction
11.11.4 Rho, Inc. Revenue in Clinical Development Services Business (2017-2022)
11.11.5 Rho, Inc. Recent Development
11.12 Synteract
11.12.1 Synteract Company Detail
11.12.2 Synteract Business Overview
11.12.3 Synteract Clinical Development Services Introduction
11.12.4 Synteract Revenue in Clinical Development Services Business (2017-2022)
11.12.5 Synteract Recent Development
11.13 ICBio CRO
11.13.1 ICBio CRO Company Detail
11.13.2 ICBio CRO Business Overview
11.13.3 ICBio CRO Clinical Development Services Introduction
11.13.4 ICBio CRO Revenue in Clinical Development Services Business (2017-2022)
11.13.5 ICBio CRO Recent Development
11.14 Sofpromed
11.14.1 Sofpromed Company Detail
11.14.2 Sofpromed Business Overview
11.14.3 Sofpromed Clinical Development Services Introduction
11.14.4 Sofpromed Revenue in Clinical Development Services Business (2017-2022)
11.14.5 Sofpromed Recent Development
11.15 Profil
11.15.1 Profil Company Detail
11.15.2 Profil Business Overview
11.15.3 Profil Clinical Development Services Introduction
11.15.4 Profil Revenue in Clinical Development Services Business (2017-2022)
11.15.5 Profil Recent Development
11.16 ICON plc
11.16.1 ICON plc Company Detail
11.16.2 ICON plc Business Overview
11.16.3 ICON plc Clinical Development Services Introduction
11.16.4 ICON plc Revenue in Clinical Development Services Business (2017-2022)
11.16.5 ICON plc Recent Development
11.17 Clinipace
11.17.1 Clinipace Company Detail
11.17.2 Clinipace Business Overview
11.17.3 Clinipace Clinical Development Services Introduction
11.17.4 Clinipace Revenue in Clinical Development Services Business (2017-2022)
11.17.5 Clinipace Recent Development
11.18 OCT Clinical
11.18.1 OCT Clinical Company Detail
11.18.2 OCT Clinical Business Overview
11.18.3 OCT Clinical Clinical Development Services Introduction
11.18.4 OCT Clinical Revenue in Clinical Development Services Business (2017-2022)
11.18.5 OCT Clinical Recent Development
11.19 EPS Group
11.19.1 EPS Group Company Detail
11.19.2 EPS Group Business Overview
11.19.3 EPS Group Clinical Development Services Introduction
11.19.4 EPS Group Revenue in Clinical Development Services Business (2017-2022)
11.19.5 EPS Group Recent Development
11.20 Beijing Sun-novo Pharmaceutical Research
11.20.1 Beijing Sun-novo Pharmaceutical Research Company Detail
11.20.2 Beijing Sun-novo Pharmaceutical Research Business Overview
11.20.3 Beijing Sun-novo Pharmaceutical Research Clinical Development Services Introduction
11.20.4 Beijing Sun-novo Pharmaceutical Research Revenue in Clinical Development Services Business (2017-2022)
11.20.5 Beijing Sun-novo Pharmaceutical Research Recent Development
11.21 Dmedglobal
11.21.1 Dmedglobal Company Detail
11.21.2 Dmedglobal Business Overview
11.21.3 Dmedglobal Clinical Development Services Introduction
11.21.4 Dmedglobal Revenue in Clinical Development Services Business (2017-2022)
11.21.5 Dmedglobal Recent Development
11.22 WuXi AppTec
11.22.1 WuXi AppTec Company Detail
11.22.2 WuXi AppTec Business Overview
11.22.3 WuXi AppTec Clinical Development Services Introduction
11.22.4 WuXi AppTec Revenue in Clinical Development Services Business (2017-2022)
11.22.5 WuXi AppTec Recent Development
11.23 Elixir Clinical Research
11.23.1 Elixir Clinical Research Company Detail
11.23.2 Elixir Clinical Research Business Overview
11.23.3 Elixir Clinical Research Clinical Development Services Introduction
11.23.4 Elixir Clinical Research Revenue in Clinical Development Services Business (2017-2022)
11.23.5 Elixir Clinical Research Recent Development
11.24 IBM
11.24.1 IBM Company Detail
11.24.2 IBM Business Overview
11.24.3 IBM Clinical Development Services Introduction
11.24.4 IBM Revenue in Clinical Development Services Business (2017-2022)
11.24.5 IBM Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
